4506

COM:SUMITOMO-PHARMA

Sumitomo Pharma Co., Ltd.

  • Stock

Last Close

611.00

22/11 02:04

Market Cap

162.09B

Beta: -

Volume Today

1.09M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
60.91B
-
60.76B
0.25%
60.99B
0.37%
64.20B
5.26%
64.49B
0.45%
63.53B
1.49%
73.13B
15.11%
85.79B
17.32%
95.62B
11.45%
96.71B
1.15%
average payables
12.98B
-
12.10B
6.78%
12.32B
1.82%
13.33B
8.20%
36.61B
174.58%
53.97B
47.42%
55.74B
3.28%
63.44B
13.81%
55.41B
12.66%
49.16B
11.28%
average receivables
176.17B
-
190.83B
8.32%
205.29B
7.58%
204.10B
0.58%
151.01B
26.01%
116.32B
22.97%
131.96B
13.44%
140.37B
6.37%
143.78B
2.43%
128.81B
10.41%
book value per share
1.00K
-
1.14K
13.17%
1.12K
1.01%
1.16K
3.18%
1.14K
1.72%
1.25K
10.03%
1.33K
6.29%
1.46K
9.65%
1.53K
4.71%
1.02K
33.09%
capex per share
-54.26
-
-31.12
42.63%
-24.52
21.24%
-33.88
38.18%
-31.09
8.21%
-32.50
4.53%
-33.60
3.38%
-27.20
19.06%
-33.96
24.88%
-32.07
5.57%
capex to depreciation
-0.81
-
-0.64
20.11%
-0.48
25.27%
-0.72
50.41%
-0.96
32.60%
-0.92
3.61%
-0.77
16.79%
-0.48
38.01%
-0.35
26.17%
-0.31
12.24%
capex to operating cash flow
-0.43
-
-0.41
5.29%
-0.20
51.78%
-0.62
215.77%
-0.13
78.75%
-0.27
100.48%
-0.29
9.17%
-0.08
72.47%
-0.43
442.05%
-1.07
147.11%
capex to revenue
-0.06
-
-0.03
40.11%
-0.02
27.45%
-0.03
35.35%
-0.03
19.06%
-0.03
6.26%
-0.03
1.64%
-0.02
24.27%
-0.02
15.05%
-0.02
4.81%
cash per share
263.52
-
357.02
35.48%
342.21
4.15%
265.80
22.33%
427.49
60.83%
455.69
6.60%
328.28
27.96%
561.75
71.12%
600.51
6.90%
411.92
31.41%
days of inventory on hand
207.33
-
224.95
8.50%
208.19
7.45%
250.95
20.54%
195.48
22.10%
215.01
9.99%
223.40
3.91%
244.30
9.36%
230.02
5.85%
192.59
16.27%
days payables outstanding
41.06
-
45.04
9.70%
42.46
5.73%
52.93
24.67%
190.74
260.33%
158.27
17.02%
175.22
10.71%
171.24
2.27%
107.28
37.35%
106.37
0.85%
days sales outstanding
179.50
-
187.71
4.58%
198.78
5.89%
167.25
15.86%
88.66
46.99%
94.77
6.89%
109.39
15.43%
96.25
12.01%
98.74
2.58%
69.73
29.38%
debt to assets
0.14
-
0.12
15.65%
0.07
40.72%
0.09
18.83%
0.06
31.65%
0.04
36.68%
0.24
541.65%
0.21
11.99%
0.21
1.73%
0.29
43.40%
debt to equity
0.24
-
0.19
19.52%
0.11
40.44%
0.15
29.20%
0.10
29.07%
0.06
40.68%
0.56
806.07%
0.47
16.19%
0.44
6.16%
0.82
85.93%
dividend yield
0.01
-
0.01
15.17%
0.01
9.88%
0.01
29.50%
0.01
14.32%
0.01
9.01%
0.02
130.81%
0.01
38.23%
0.02
59.61%
0.03
49.12%
earnings yield
0.03
-
0.03
11.32%
0.05
75.67%
0.04
17.23%
0.08
89.73%
0.04
40.87%
0.07
64.15%
0.05
34.20%
0.08
75.85%
-0.30
455.26%
enterprise value
723.84B
-
621.73B
14.11%
510.99B
17.81%
726.83B
42.24%
609.20B
16.18%
985.42B
61.76%
753.68B
23.52%
845.71B
12.21%
545.99B
35.44%
513.04B
6.03%
enterprise value over ebitda
10.58
-
14.98
41.58%
9.27
38.10%
9.88
6.52%
5.89
40.40%
12.44
111.29%
7.23
41.83%
8.20
13.37%
4.39
46.47%
-146.67
3,440.60%
ev to operating cash flow
14.49
-
20.55
41.81%
10.34
49.69%
33.61
225.04%
6.52
80.60%
20.23
210.22%
16.34
19.23%
6.24
61.83%
17.48
180.24%
42.98
145.91%
ev to sales
1.87
-
1.67
10.33%
1.27
24.30%
1.77
39.32%
1.30
26.09%
2.15
64.42%
1.56
27.23%
1.64
4.99%
0.97
40.52%
0.92
5.28%
free cash flow per share
71.45
-
45.02
37.00%
99.86
121.84%
20.55
79.42%
204.04
892.85%
90.10
55.84%
82.50
8.44%
314.11
280.74%
44.66
85.78%
-2.03
104.54%
free cash flow yield
0.04
-
0.03
27.44%
0.08
143.75%
0.01
85.49%
0.11
921.76%
0.03
71.30%
0.06
79.34%
0.16
177.21%
0.04
77.32%
-0.00
106.77%
graham net net
42.22
-
140.25
232.19%
174.17
24.19%
-130.44
174.89%
-181.19
38.90%
-82.20
54.63%
-861.22
947.77%
-726.46
15.65%
-585.77
19.37%
-1.10K
88.00%
graham number
1.07K
-
996.52
6.65%
1.25K
25.81%
1.38K
10.05%
1.86K
34.61%
1.86K
0.05%
1.75K
5.62%
1.75K
0.46%
1.88K
7.44%
2.37K
26.25%
income quality
1.44
-
0.90
37.72%
1.25
39.38%
0.46
63.34%
1.75
281.65%
1.00
42.69%
1.28
28.20%
3.68
186.70%
0.77
79.10%
-0.12
116.04%
intangibles to total assets
0.24
-
0.24
2.70%
0.22
9.45%
0.38
73.24%
0.35
8.24%
0.32
7.78%
0.47
45.39%
0.43
9.24%
0.45
6.07%
0.47
4.57%
interest coverage
41.85
-
24.84
40.64%
40.18
61.77%
83.61
108.07%
15.37
81.62%
279.63
1,719.44%
29.10
89.59%
27.54
5.37%
28.20
2.39%
-24.37
186.41%
interest debt per share
241.64
-
220.13
8.90%
130.70
40.62%
172.74
32.16%
133.75
22.58%
78.40
41.38%
757.22
865.88%
695.72
8.12%
684.88
1.56%
850.45
24.17%
inventory turnover
1.76
-
1.62
7.83%
1.75
8.05%
1.45
17.04%
1.87
28.37%
1.70
9.08%
1.63
3.76%
1.49
8.56%
1.59
6.21%
1.90
19.44%
invested capital
0.24
-
0.19
19.52%
0.11
40.44%
0.15
29.20%
0.10
29.07%
0.06
40.68%
0.56
806.07%
0.47
16.19%
0.44
6.16%
0.82
85.93%
market cap
651.58B
-
565.76B
13.17%
514.90B
8.99%
730.24B
41.82%
709.58B
2.83%
1.09T
53.86%
557.40B
48.94%
765.59B
37.35%
479.93B
37.31%
321.81B
32.95%
net current asset value
99.12B
-
141.14B
42.39%
160.34B
13.61%
43.16B
73.08%
-8.38B
119.42%
36.69B
537.82%
-256.68B
799.62%
-200.15B
22.02%
-134.92B
32.59%
-346.10B
156.53%
net debt to ebitda
1.06
-
1.35
27.69%
-0.07
105.26%
-0.05
34.76%
-0.97
1,994.28%
-1.34
38.40%
1.88
240.36%
0.78
58.76%
0.53
31.63%
-54.67
10,391.22%
net income per share
50.49
-
38.88
23.00%
62.16
59.88%
72.97
17.39%
134.53
84.36%
122.39
9.02%
102.58
16.19%
92.70
9.63%
102.19
10.24%
-243.43
338.21%
operating cash flow per share
125.70
-
76.14
39.43%
124.38
63.35%
54.43
56.24%
235.14
332.02%
122.61
47.86%
116.11
5.30%
341.31
193.97%
78.63
76.96%
30.05
61.79%
payables turnover
8.89
-
8.10
8.84%
8.60
6.08%
6.90
19.79%
1.91
72.25%
2.31
20.52%
2.08
9.68%
2.13
2.32%
3.40
59.62%
3.43
0.86%
receivables turnover
2.03
-
1.94
4.38%
1.84
5.56%
2.18
18.85%
4.12
88.63%
3.85
6.44%
3.34
13.37%
3.79
13.65%
3.70
2.52%
5.23
41.61%
research and ddevelopement to revenue
0.18
-
0.19
6.64%
0.20
5.96%
0.20
3.50%
0.19
5.16%
0.22
19.70%
0.24
6.99%
0.26
7.84%
0.17
34.10%
0.24
40.06%
return on tangible assets
0.04
-
0.03
28.08%
0.04
55.99%
0.06
32.13%
0.10
71.97%
0.09
15.32%
0.06
28.61%
0.05
20.04%
0.06
15.50%
-0.16
385.44%
revenue per share
975.84
-
934.72
4.21%
1.01K
8.57%
1.04K
2.09%
1.18K
13.41%
1.16K
1.62%
1.22K
5.11%
1.30K
6.88%
1.41K
8.54%
1.40K
0.80%
roe
0.05
-
0.03
31.96%
0.06
61.51%
0.06
13.77%
0.12
87.59%
0.10
17.31%
0.08
21.15%
0.06
17.58%
0.07
5.29%
-0.24
456.01%
roic
0.05
-
0.02
59.85%
0.05
133.87%
0.06
32.22%
0.11
81.20%
0.08
26.34%
0.04
47.38%
0.04
8.38%
0.05
21.71%
-0.21
536.53%
sales general and administrative to revenue
0.39
-
0.39
0.13%
0.32
18.62%
0.37
15.40%
0.44
20.54%
0.67
51.09%
shareholders equity per share
1.00K
-
1.14K
13.17%
1.12K
1.01%
1.16K
3.18%
1.14K
1.72%
1.25K
10.03%
1.33K
6.29%
1.46K
9.65%
1.53K
4.71%
1.02K
33.09%
stock based compensation to revenue
tangible asset value
241.74B
-
277.16B
14.65%
289.89B
4.59%
156.35B
46.07%
167.94B
7.42%
227.40B
35.40%
41.27B
81.85%
88.28B
113.92%
79.73B
9.68%
-131.95B
265.49%
tangible book value per share
608.45
-
697.60
14.65%
729.65
4.59%
393.52
46.07%
422.72
7.42%
572.37
35.40%
103.87
81.85%
222.20
113.92%
200.69
9.68%
-332.12
265.49%
working capital
228.40B
-
244.86B
7.20%
241.86B
1.22%
148.01B
38.81%
138.33B
6.54%
175.09B
26.57%
-132.41B
175.62%
181.65B
237.19%
221.15B
21.75%
9.17B
95.86%

All numbers in (except ratios and percentages)